Insider Trading - 5AM Co-Investors IV L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for 5AM Co-Investors IV L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2022-04-11 Sale	2022-04-13 4:51 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	270,000	$5	$1,350,000	537,301 (Indirect)	View
2020-12-22 Sale	2020-12-28 9:35 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.82	$6,410,000	181,435 (Indirect)	View
2020-12-14 Sale	2020-12-16 7:15 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	500,000	$12.25	$6,125,915	201,435 (Indirect)	View
2020-11-11 Sale	2020-11-13 8:53 pm	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M 10% Owner	800,000	$13.66	$10,928,000	384,496 (Indirect)	View
2020-10-05 Sale	2020-10-07 9:30 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder	175,000	$25.3	$4,427,500	2,037,654 (Indirect)	View
2020-06-16 Sale	2020-06-18 7:22 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	140,000	$33.3	$4,662,000	313,497 (Indirect)	View
2020-06-11 Sale	2020-06-15 9:12 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	245,000	$28.75	$7,044,412	414,105 (Indirect)	View
2020-05-19 Sale	2020-05-21 9:31 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC PARMAR KUSH 10% Owner	255,000	$35.15	$8,963,250	423,905 (Indirect)	View
2019-10-07 Purchase	2019-10-09 6:23 pm	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	333,333	$15	$4,999,995	333,333 (Indirect)	View
2019-06-21 Sale	2019-06-25 7:03 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. Former 10% holder	250,000	$22.2	$5,550,000	94,489 (Indirect)	View
2019-05-28 Purchase	2019-05-28 8:40 pm	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	750,000	$10	$7,500,000	500,000 (Indirect)	View
2019-05-16 Sale	2019-05-20 4:26 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	615,000	$21.47	$13,204,050	221,435 (Indirect)	View
2019-03-18 Sale	2019-03-20 4:48 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	154,839	$24.25	$3,754,954	104,489 (Indirect)	View
2019-01-22 Sale	2019-01-24 7:01 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	262,153	$21.88	$5,734,597	129,483 (Indirect)	View
2018-12-10 Sale	2018-12-12 8:10 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	15,575	$26.01	$405,029	246,035 (Indirect)	View
2018-11-23 Sale	2018-11-27 6:08 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	29,682	$20.04	$594,709	246,658 (Indirect)	View
2018-11-16 Sale	2018-11-20 5:05 pm	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	525,900	$20.2	$10,623,180	247,845 (Indirect)	View
2018-07-20 Purchase	2018-07-20 7:02 pm	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	115,000	$17	$1,955,000	139,969 (Indirect)	View
2017-11-21 Purchase	2017-11-21 7:16 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. Schwab Andrew J. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	654,762	$14	$9,166,668	130,135 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2021-12-03 Ownership	2021-12-13 4:26 pm	N/A N/A	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	0	$0	18,631,771 (Indirect)	View
2019-10-07 Conversion	2019-10-09 6:23 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner	2,506,650	$0	333,333 (Indirect)	View
2019-10-02 Ownership	2019-10-02 7:31 pm	N/A N/A	Aprea Therapeutics Inc.	APRE	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	2,519,320 (Indirect)	View
2019-05-28 Conversion	2019-05-28 8:40 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	2,396,191	$0	500,000 (Indirect)	View
2019-05-22 Ownership	2019-05-23 12:21 pm	N/A N/A	IDEAYA Biosciences Inc.	IDYA	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	0	$0	2,713,066 (Indirect)	View
2019-02-20 Other	2019-02-22 8:06 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	477,363	$0	486,292 (Indirect)	View
2018-07-20 Conversion	2018-07-20 7:02 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	14,518,556	$0	139,969 (Indirect)	View
2018-07-17 Ownership	2018-07-17 8:14 pm	N/A N/A	Crinetics Pharmaceuticals Inc.	CRNX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	3,384,278 (Indirect)	View
2018-04-02 Conversion	2018-04-04 6:41 pm	N/A N/A	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner	10,784,074	$0	6,722,076 (Indirect)	View
2018-03-27 Ownership	2018-03-27 8:47 pm	N/A N/A	Homology Medicines Inc.	FIXX	5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner	0	$0	6,722,076 (Indirect)	View
2017-11-21 Conversion	2017-11-21 7:16 pm	N/A N/A	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. Schwab Andrew J. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	21,257,687	$0	130,135 (Indirect)	View
2017-11-16 Ownership	2017-11-16 9:15 pm	N/A N/A	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. Schwab Andrew J. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner	0	$0	18,659,012 (Indirect)	View